City
Epaper

All barriers for authorisation of Sputnik V vax removed: Russia

By IANS | Updated: October 2, 2021 19:50 IST

New Delhi, Oct 2 All barriers preventing the authorisation of the Russian Sputnik V vaccine against coronavirus by ...

Open in App

New Delhi, Oct 2 All barriers preventing the authorisation of the Russian Sputnik V vaccine against coronavirus by the World Health Organisation have been removed, Russia's health minister said in a tweet on Saturday.

"All barriers for SputnikV authorisation by WHO have been removed, only minor administrative procedures need to be sorted. It has been confirmed by @WHO Director-General @DrTedros," Russia's Health Minister Mikhail Murashko tweeted.

Developed by Russia's Gamaleya National Center, the Sputnik V jab is currently registered in 70 countries with a population of over 4 billion people. Sputnik V received an emergency use authorisation in India in April. The vaccine uses two different vectors for the two shots in a course of vaccination. Its efficacy was determined to be 91.6 per cent.

"The position of the Russian Federation on promoting and registering the Russian Sputnik V vaccine was heard. We have completely resolved all issues to date,"Murashko said at a briefing in Geneva to TASS news agency.

The health minister said that he discussed the procedure of including Sputnik V in the list of vaccines recommended by the WHO for the emergency use listing against Covid infection with Director General Tedros Adhanom Ghebreyesus.

"The applicant company involved in certifying the Sputnik V vaccine with the WHO has to sign a number of documents, submit some additional paperwork this is an administrative procedure after all and this will be reviewed," he explained.

"As of today, all the barriers have been removed. So we do not see today any obstacles for further work. And this was confirmed to us by the WHO Director General," the minister added.

Ghebreyesus in a tweet thanked the Russian health minister for the visit, saying the meeting was "constructive" and shared that they discussed efforts to fight Tuberculosis and non-communicable diseases.

Russia first applied for approval from the WHO for their vaccine in February but has not yet received an emergency use listing.

Last week, the WHO had suspended the approval process for Russia's Sputnik V Covid vaccine. According to a regional WHO official, the manufacturing process of the jab had not met the necessary standards, the Euronews reported.

The WHO said it has delayed approving the jab until a new inspection can be carried out at one of the plants where Sputnik V was manufactured.

Earlier this year, the WHO had inspected four Russian production sites within the framework of the preliminary evaluation of Sputnik V, publishing remarks on one of them. Another inspection will be possible after the production site makes appropriate adjustments.

The WHO has, so far, recommended seven vaccines against coronavirus for the Emergency Use Listing. Additionally, 13 other applications are at the various stages of the review process, including the Russian Sputnik V and EpiVacCorona vaccines.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Gamaleya national centerNew DelhiGenevaWorld Health OrganisationThe new delhi municipal councilMikhail murashkoDelhi south-westNew-delhi
Open in App

Related Stories

InternationalUS Government Shutdown: US Embassy in India’s X Account to Pause Regular Updates Until Full Operations Resume

CricketIND-W vs AUS-W, 3rd ODI: Australia Women Win Toss, Opt to Bat Against India in Series Decider; Check Playing XIs

CricketWhy Is India Women’s Cricket Team Wearing a Pink Jersey in IND-W vs AUS-W 3rd ODI 2025 Match?

CricketIND-W vs AUS-W 3rd ODI LIVE Cricket Streaming: When and Where to Watch India Women vs Australia Women Final Match

EntertainmentBhumi Satish Pednekar Becomes the First Indian Actress to Attend the Young Global Leaders Summit 2025 in Geneva

Health Realted Stories

HealthCentre launches adoption awareness campaign for children with special needs

HealthDPIIT, Thermo Fisher Scientific tie up to boost India’s biotech startup ecosystem

Health‘Cough syrup not contaminated’: MP Dy CM on death of six children in Chhindwara

HealthCabinet okays Phase III of Biomedical Research Career Programme for an outlay of Rs 3,000 cr

HealthPakistan: Islamabad reports 52 dengue cases in single day